摘要
目的:观察脑安胶囊治疗中风恢复期气虚血瘀型的临床疗效。方法:将中风恢复期气虚血瘀型患者76例随机分治疗组39例和对照组37例,对照组给予常规对症治疗,包括抗凝,抗血小板聚集,脑保护,控制血糖、血压等;治疗组在常规治疗的同时给予脑安胶囊口服2#bid,连续治疗30d。观察治疗前后2组患者临床疗效和神经功能缺损(NDS)评分变化情况。结果:治疗组显著进步率(61.6%)及总进步率(94.9%)均分别高于对照组显著进步率(32.4%)及总进步率(75.7%),两组差异有统计学意义(P<0.05)。两组治疗后神经功能缺损评分均下降,而治疗组NDS评分下降优于对照组(P<0.05)。结论:脑安胶囊在治疗中风恢复期气虚血瘀型疗效肯定。
Objective：To observe Capsule treatment of brain stroke recovery clinical efficacy of qi and blood stasis type. Methods：stroke recovery QDBS 76 patients were randomly divided into treatment group and control group 39 cases of 37 cases, the control group received conventional symptomatic treatment, including anticoagulant, anti-platelet aggregation, cerebral protection, control blood sugar, blood pressure, etc. The treatment group received oral capsules while Naoan conventional treatment 2 # bid, continuous treatment 30d.Before and after treatment, and clinical efficacy of two groups of patients neurological deficit （NDS） score changes. Results：The rate of progress in the treatment group were significantly （61.6%） and total improvement rate （ 94.9%） , respectively, were significantly higher improvement rate （ 32.4% ） and total improvement rate （ 75.7% ）.The difference was statistically significant （P 〈0.05）.After treatment of neurological deficit scores were decreased. NDS score decreased in the treatment group than the control group （P 〈0.05）.Conclusion Capsule in the treatment of cerebral stroke recovery QDBS more effective.
出处
《大众科技》
2013年第12期132-133,共2页
Popular Science & Technology
